PROPRIEDADES TERAPÊUTICAS DOS COMPOSTOS DO TIPO CANNABIGEROL: UMA REVISÃO
Keywords:
cannabis sativa, Δ9 tetraidrocanabinol, canabigerol, atividade psicoativaAbstract
A busca por compostos farmacologicamente ativos e que não apresentem efeitos tóxicos, intensifica os estudos e pesquisas sobre material de origem vegetal e seu potencial uso na farmacoterapia. Uma das plantas que tem grande potencial terapêutico e tem sido bastante estudada ultimamente é a Cannabis sativa. Os compostos mais conhecidos são o Δ9 tetraidrocanabinol (Δ9-THC) e o canabidiol (CBD), onde o Δ9-THC é o principal componente psicoativo, responsável pelos efeitos eufóricos da canabis. Mas atualmente, a atenção tem sido voltada aos fitocanabinoides que não apresentam atividade psicoativa, mas que mesmo assim, modificam o metabolismo celular beneficamente, como o CBD e mais recentemente, o CBG, que é o precursor de outros canabinoides, e por isso é encontrado em menor quantidade na planta.
References
Jastrząb, A.; Jarocka-Karpowicz, I.; Skrzydlewska, E. The origin and biomedical relevance of cannabigerol. International Journal of Molecular Sciences, 23(14). Poland, 2022.
Jeong, G.H.; Kim, K.C.; Lee, J.H. Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway. Cells 14, no. 2. Korea, 2025.
Vernail, V.; Bingaman, S.; Silberman, Y.; Raup-Konsavage, W.; Vrana, K.; Arnold, A. Acute cannabigerol administration lowers blood pressure in mice. Vol. 13. Hershey, 2022.
ElSohly, M.A., Radwan, M.M., Gul, W., Chandra, S., Galal, A. Phytochemistry of Cannabis sativa L.. In: Kinghorn, A., Falk, H., Gibbons, S., Kobayashi, J. (eds) Phytocannabinoids. Progress in the Chemistry of Organic Natural Products, vol 103. Mississipi, 2017.
Fordjour, E.; Manful, C.; Sey, A.; Javed, R.; Pham, T.H.; Thomas, R.; Cheema, M. Cannabis: a multifaceted plant with endless potentials. Poland: Jagiellonian University Medical College, 2023.
Kogan, N.M.; Lavi, Y.; Topping, L.M.; Williams, R.O.; McCann, F.E.; Yekhtin, Z.; Feldmann, M.; Gallily, R.; Mechoulam, R. Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity. Molecules, 2021.
Li, S.; Li, W.; Malhi, N.K.; Huang, J.; Li, Q.; Zhou, Z.; Wang, R.; Peng, J.; Yin, T.; Wang, H. Cannabigerol (CBG): A Comprehensive Review of Its Molecular Mechanisms and Therapeutic Potential. Molecules, 2024.
Elsohly, M.; Slade, D. Chemical constituents of marijuana: The complex mixture of natural cannabinoids. Mississipi, Elsevier: 2005.
Cuttler, C., Stueber, A., Cooper, Z.D. et al. Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial. Washington, Sci Rep 14: 2024.
Suzuki, S.; Wakano, C.; Monteilh-Zoller, M.; Cullen, A.; Fleig, A.; Penne, R. Cannabigerolic acid (CBGA) inhibits the TRPM7 Ion Channel through its kinase domain. Oxford, Oxford university: 2023.
Anderson, B.; Sepulveda, D.; Nachnani, R.; Cortez-Resendiz, A.; Coates, M.; Beckett, A.; Bisanz, J.; Kellogg, J.; Raup-Konsavage, W. High cannabigerol hemp extract moderates colitis and modulates the microbiome in an inflammatory bowel disease model. Pennsylvania, 2024.
Anderson, L.; Heblinski, M.; Absalom, N.; Hawkins,N.; Bowen, M.; Benson, M.; Zhang, F.; Bahceci, D.; Doohan, P.; Chebib, M.; McGregor, I.; Kearney, J.; Arnold, J. Cannabigerolic acid, a major biosynthetic precursor molecule incannabis, exhibits divergent effects on seizures in mousemodels of epilepsy. British Pharmacological Societ: 2021.
Downloads
Published
Issue
Section
License
These Proceedings offer free and immediate access to their content, based on the principle that making scientific knowledge freely available to the public fosters the global democratization of knowledge.
Upon publication in the Proceedings, authors retain copyright and publication rights to their articles without restriction.
The Proceedings of the International Congress on Research, Teaching, and Extension (CIPEEX) of the Evangelical University of Goiás (UniEVANGÉLICA) adhere to the terms of the Creative Commons Attribution-NonCommercial 4.0 International license.
